Diomed acquires exclusive rights to EVLT (endovenous laser treatment for varicose veins) technology:
This article was originally published in Clinica
Executive Summary
Diomed Holdings is acquiring exclusive patent rights to the technology used in its endovenous laser treatment for varicose veins (EVLT). In separate agreements it is purchasing the US rights from the patent holders, Dr Robert Min and Endolaser Associates. Until now the Andover, Massachusetts firm has only had a non-exclusive technology licence for the FDA-approved procedure. The acquisition was enabled by the firm's recent $21.3m financing.